NovoCureNVCR

那斯達克 · USD
14.18
-0.17
(-1.18%)
收盤 01/13 04:59 (UTC+8)
01/13 04:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 1.26
  • 1.27
  • 1.34
  • 1.39
  • 1.50
  • 1.55
  • 1.61
  • 1.55
  • 1.59
  • 1.67
icon
  • 3.17
  • 1.01
  • 5.08
  • 3.53
  • 8.56
  • 3.15
  • 3.98
  • -3.89
  • 2.46
  • 5.29
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
營業收入淨額
167,204
158,805
154,994
161,266
155,095
150,356
138,503
133,784
127,321
126,051
營業成本
44,72941,47238,52133,46635,37234,65433,68932,55632,09234,018
營業毛利
122,475
117,333
116,473
127,800
119,723
115,702
104,814
101,228
95,229
92,033
營業費用
158,496156,854154,338191,104151,815149,282146,334152,944153,474154,693
研發費用
54,02955,83353,77751,21051,88254,95551,59854,30853,62355,427
推銷及管理費用
104,467101,021100,561139,89499,93394,32794,73698,63699,85199,266
非經常性項目費用
----------
其他營業費用
----------
營業利益
-36,021
-39,521
-37,865
-63,304
-32,092
-33,580
-41,520
-51,716
-58,245
-62,660
其他收入及費用
----------
利息費用
----------
稅前純益
-30,022
-34,979
-30,295
-55,206
-21,585
-22,729
-31,642
-38,534
-48,222
-53,904
所得稅
7,2485,1604,02410,7168,98510,6467,1188,5451,2633,514
稅後純益
-37,270
-40,139
-34,319
-65,922
-30,570
-33,375
-38,760
-47,079
-49,485
-57,418
基本每股稅後盈餘(元)
-0.33-0.36-0.31-0.61-0.28-0.31-0.36-0.45-0.46-0.54
稀釋每股稅後盈餘(元)
-0.33-0.36-0.31-0.61-0.28-0.31-0.36-0.44-0.47-0.54
基本平均股數(千股)
111908.00111572.00110281.00108474.00108247.00107700.00107266.00106983.00106772.00106289.00
稀釋平均股數(千股)
111908.00111572.00110281.00108474.00108247.00107700.00107266.00106983.00106772.00106289.00
還原基本每股稅後盈餘(元)
-0.33-0.36-0.31-0.61-0.28-0.31-0.36-0.45-0.46-0.54
還原稀釋每股稅後盈餘(元)
-0.33-0.36-0.31-0.61-0.28-0.31-0.36-0.44-0.47-0.54
還原基本平均股數(千股)
111,908111,572110,281108,474108,247107,700107,266106,983106,772106,289
還原稀釋平均股數(千股)
111,908111,572110,281108,474108,247107,700107,266106,983106,772106,289
EBITDA(千元)
-32,761-37,995-33,624-58,774-25,864-26,725-34,208-43,073-52,110-56,258

大家都在看

HOT